MedPoint Launches New Study Document Exchange System
MedPoint Communications Inc.
announced that it is launching a new service, the Study Document Exchange (SDX) System. This new service aims to optimize the regulatory document completion process by providing a rapid, centralized platform to support the flow of documents among sites, sponsors and CROs.
The SDX system operates stand-alone or within an ePortal, and provides support for single or multiple studies, a compound development program, or an enterprise-wide drug development pipeline. All downloaded documents are tracked for up-to-the-minute accuracy in reporting, and completed forms can be printed for record-keeping and compliance. The SDX system supports electronic signatures, incorporates security features, adheres to 21 CFR Part 11, and is considered a closed system.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
